INTRODUCTION 53
The genome is continuously exposed to mutagenic processes, which can damage the DNA 54 and can ultimately result in the accumulation of mutations. To counteract these processes, 55 cells exploit multiple DNA repair pathways that each repair specific lesions. Deficiency of 56 these pathways can contribute to cancer initiation and progression. To increase insight into 57 the cellular processes that underlie mutation accumulation, such as deficiency of specific 58 DNA repair pathways, genome-wide mutational patterns of tumors can be characterized 59 (Alexandrov et processes that cause specific mutational signatures. We recently developed an approach for 74 measuring mutations in non-cancerous adult stem cells (ASCs), by combining organoid 75 culturing technology with whole-genome sequencing (WGS) (Jager et al. 2018; Drost et al. 76 2017). This method can be used to determine the mutations that have accumulated during 77 life and during culturing. Tissue-specific ASCs maintain a highly stable genome both in vivo 78 and in vitro, and therefore provide a stable system to study mutational processes in detail 79 (Blokzijl et al. 2016; Huch et al. 2015) . Furthermore, ASCs constitute a relevant cell source 80 to study mutational patterns, as these cells are believed to be the cell-of-origin for specific 81 types of cancer (Barker et al. 2009 ; Zhu et al. 2016 ; Adams et al. 2015) . 82
Using this technique, we set out to determine the mutational consequences of 83 deficiency of nucleotide excision repair (NER). NER is one of the main cellular DNA repair 84 pathways (Iyama and Wilson 2013) , and consists of two subpathways: global-genome NER 85 (GG-NER), which repairs bulky helix-distorting lesions throughout the genome, and 86 transcription-coupled NER (TC-NER), which resolves RNA polymerase blocking lesions 87 during transcription (Iyama and Somatic mutations in ERCC2, a key factor of NER, were previously associated with 89
Signature 5 in urothelial tumors (Kim et al. 2016 ). However, NER has been suggested to 90 underlie multiple mutational signatures, based on large-scale tumor mutation analyses 91 (Alexandrov et al. 2013) , and not all NER-deficient tumors are characterized by a high 92
Signature 5 contribution (Kim et al. 2016 ). This observation suggests that NER-deficiency 93 might be associated with other mutational signatures as well. 94
To characterize the mutational consequences of NER-deficiency, we studied 95 mutagenesis in Ercc1 -/Δ mice and XPC-knockout (XPC KO linked to an increased risk of developing colorectal cancer (Ni et al. 2014 ). Ercc1 -/Δ mice are 102 hemizygous for a single truncated Ercc1 allele, which largely corrupts protein function (Dollé 103 et al. 2011; Weeda et al. 1997 ) and results in decreased NER-activity (Su et al. 2012) . 104
Ercc1
-/Δ mice have a reduced lifespan as a result of progeroid-like symptoms and live five 105 times shorter than wild-type (WT) littermates (Dollé et by enhanced sensitivity to UV-light and development of various cancer types at an early age 114 (Sands et al. 1995; Melis et al. 2008; Dupuy and Sarasin 2015) . 115
Here, we combined the organoid culture system with in vivo and in vitro knockout 116 models, providing the unique opportunity to characterize the genome-wide mutational 117 consequences of NER-deficiency in a stable genetic background. Furthermore, we 118 compared the genome-wide mutational patterns of NER-deficient and NER-proficient tumors 119 from a breast cancer cohort (Nik-Zainal et al. 2016 ). Both quantitative and qualitative 120 mutational differences that are associated with NER status were identified, creating novel 121 insight into the molecular processes underlying mutation accumulation, cancer, and aging. 122
123

RESULTS
124
Loss of NER protein ERCC1 increases the number of base substitutions in liver, but 125 not in small intestinal mouse ASCs 126
To characterize the mutational consequences of NER-deficiency, we generated clonal 127 organoid cultures from single liver and small intestinal ASCs of three female Ercc1 -/Δ mice 128 and three female WT littermates (Fig. 1A) . The tissues were harvested at the age of 15 129 weeks, which is the time point at which Ercc1 -/Δ mice generally start to die as a consequence 130 of early aging pathologies (Vermeij et al. 2016 ). WGS analysis of DNA isolated from the 131 clonal organoid cultures allows for reliable determination of the somatic mutations that were 132 accumulated during life in the original ASCs (Blokzijl et al. 2016; Jager et al. 2018) . 133
Subclonal mutations acquired after the single-cell-step will only be present in a 134 subpopulation of the cells and are filtered out based on a low allele frequency (Jager et al. 135 2018). We also sequenced the genomes of polyclonal control biopsies from the tail of each 136 mouse, which served as control samples to exclude germline variants. Schematic overview of the experimental setup used to determine the mutational patterns in 141 single ASCs from the liver and small intestine of mice. Biopsies from the liver and small 142 intestine of six 15-week-old female mice (three Ercc1 -/Δ mice and three WT littermates) were 143 cultured in bulk for ~1.5 week to enrich for ASCs. Subsequently, clonal organoids were 144 derived from these bulk organoid cultures and expanded for approximately 1 month, until 145 there were enough cells to perform both WGS and RNA sequencing. As a control sample for 146 filtering germline variants, a biopsy of the tail of each mouse was also subjected to WGS. (B) 147
Boxplots depicting normalized Ercc1 expression in ASC organoid cultures from liver and 148 small intestine of Ercc1 -/Δ mice (n = 3 and n = 3, respectively) and WT littermates (n = 3 and 149 n = 4, respectively). Asterisks represent significant differences (P < 0.05, negative binomial 150 test (Fig. 1C) . No other DNA repair genes were differentially expressed 162 between WT and Ercc1 -/Δ ASCs (Supplemental File S1). Notably, the expression of 8 out of 163 9 core NER genes, including Ercc1, is higher in WT liver ASCs than WT small intestinal 164
ASCs (Supplemental Fig. S1 , Supplemental Table S1 ). 165 WGS analysis on the clonally-expanded organoid cultures revealed 4,238 somatic 166 base substitutions in the autosomal genome of 11 clonal ASC samples ( Fig. 2A ; 167 Supplemental Table S2 ). Targeted deep-sequencing validated ~97.5% of these base 168 substitutions (Supplemental File S2). Liver ASCs of WT mice acquired 19.5 ± 4.1 (mean ± 169 standard deviation) base substitutions per week. This rate is similar in ASCs of the small 170 intestine, at 16.1 ± 3.1 mutations per week, and is in line with the observation that human 171 liver and intestinal ASCs have similar mutation accumulation rates in vivo (Blokzijl et al. 172 2016). Loss of ERCC1 induced a twofold increase (45.5 ± 3.0 base substitutions per week) 173 in the number of base substitutions in ASCs of the liver ( Fig. 2A, Supplemental Fig. S2A ). 174
However, we did not observe a different mutation rate in small intestinal ASCs of Ercc1 
Ercc1
-/Δ ASCs compared with WT. 186
In addition to the 4,238 base substitutions, we identified 2,116 small insertions and 187 deletions (indels) and 21 larger deletions (≥100 bp) in the autosomal genome of the 11 188 clonal ASC samples (Supplemental Table S2 ). As opposed to the base substitutions, we 189 observed similar indel numbers for WT and Ercc1 -/Δ ASCs of both tissues ( Table S4 ). Finally, a genome-wide copy-number 197 profile was generated to identify chromosomal gains and losses. These profiles indicated 198 that all WT and Ercc1 -/Δ ASCs were karyotypically stable during life (Supplemental Fig. S3 ). 199
Nevertheless, some subclonal aneuploidies were detected in a WT as well as an Ercc1 To further dissect the mutational consequences of NER-deficiency, we characterized the 213 mutation spectra in the mouse ASCs. Regardless of tissue-type, the mutation spectra of all 214 assessed ASCs are predominantly characterized by C:G > A:T mutations and C:G > T:A 215 mutations (Fig. 3A) . However, the mutation spectra of NER-proficient and NER-deficient 216 ASCs differed significantly for both tissues (q < 0.05, Χ 2 -test, FDR correction). Indeed, there 217 are some notable differences, such as an increased contribution of T:A > A:T mutations in 218
-/Δ ASCs compared with WT ASCs (Fig. 3A) . 219
To gain insight into these differences, we generated 96-channel mutational profiles of 220 all ASCs (Supplemental Fig. S4, Supplemental Fig. S5) transcriptional strand bias, although the mutation numbers are too low to be conclusive 289 (Supplemental Fig. S9C ). NER-deficiency thus influences both the mutation load and 290 mutation type, but not the genomic distribution of the observed base substitutions in mouse 291
ASCs, suggesting that the contribution of TC-NER in the observed mutational consequences 292 is minimal in these cells. 293
294
Loss of GG-NER protein XPC induces Signature 8 mutations in human ASCs 295
To identify a potential causal relationship between NER-deficiency and Signature 8 in human 296
ASCs, we generated a human GG-NER deficient XPC KO ASC using CRISPR-Cas9 gene-297 editing in a human small intestinal organoid culture (Fig. 4A) . After confirming absence of 298 XPC protein (Fig. 4B) , we passaged the XPC KO Supplemental Table S5 ). In addition, the number of double base substitutions acquired per 309
week was approximately 17 times higher (Fig. 4D , Supplemental Table S5 , Supplemental 310 Table S6 ). We did not observe a marked change in the genomic distribution of acquired 311 mutations as a result of XPC deletion in human ASCs, nor a change in transcriptional strand 312 bias (Supplemental Fig. S10C-D in healthy human and mouse ASCs (Fig. 3C, Fig. 4E ), this signature most likely represents a 395 mutagenic process that is generally active in normal cells and not repaired 100% effective. 396 
Mouse tissue material 474
Ercc1
-/Δ mice were generated and maintained as previously described (Vermeij et al., 2016) . 
Generation of clonal Ercc1
-/Δ and WT mouse organoid cultures 493
Single liver ASCs were isolated from livers as described previously (Kuijk et al. 2016) . Liver 494 organoid cultures were initiated by culturing the liver ASCs in BME overlaid with mouse liver 495 culture initiation medium (50% Adv+++ medium, 35% WNT3A conditioned medium 496 (produced in house), 5% NOGGIN conditioned medium (produced in house), 5% RSPOI 497 conditioned medium (produced in house), 1x B27 without retinoic acid, 1x N2, 1x Primocin, 498 10mM Nicotinamide, 0.625mM N-acetylcysteine, 100ng/ml FGF-10, 10μM ROCKi, 50 ng/ml 499 HGF, 10nM Gastrin, and 50ng/ml hEGF). 1.5 week after culture initiation, clonal organoid 500 liver cultures were generated and expanded according to protocol (Jager et al. 2018) in 501 mouse liver expansion medium (90% Adv+++ medium, 5% RSPOI conditioned medium 502 (produced in house), 1x B27 without retinoic acid, 1x N2, 1x Primocin, 10mM Nicotinamide, 503 0.625mM N-acetylcysteine, 100ng/ml FGF-10, 50 ng/ml HGF, 10nM Gastrin, and 50ng/ml 504 hEGF). 505
Crypts were isolated from small intestines as described previously (Sato et al. 2009 ). 506
Small intestinal organoid cultures were initiated by culturing the small intestinal ASCs in 507 matrigel overlaid with mouse small intestine medium (50% WNT3A conditioned medium 508 (produced in house), 30% Adv+++ medium, 10% NOGGIN conditioned medium (produced in 509 house), 10% RSPOI conditioned medium (produced in house), 1x B27, 1x hES Cell Cloning 510 & Recovery Supplement, 1x Primocin, 10μM ROCKi, 1.25mM N-acetylcysteine, and 50ng/ml 511 hEGF). Clonal small intestinal organoid cultures were generated by picking single organoids 512 manually and clonally expanding these organoid cultures according to protocol in mouse 513 small intestine medium (Jager et al. 2018 ). Culture expansion failed for the small intestine of 514 mouse WT1. 515 516
Generation of a clonal and subclonal XPC KO organoid culture 517
Clonal XPC KO organoid cultures were generated from a small intestinal bulk organoid culture 518 derived previously (Blokzijl et al. 2016 ) using the CRISPR-Cas9 gene-editing technique as 519 described in (Drost et al. 2017) . One clonal human XPC KO organoid culture was obtained 520 and cultured for 72 days in human small intestinal organoid medium (50% WNT3A 521 conditioned medium (produced in house), 30% Adv+++ medium, 20% RSPOI conditioned 522 medium (produced in house), 1x B27, 1x Primocin, 1.25mM N-acetylcysteine, 0.5μM A83-523 01, 10μM SB202190, 100ng/ml recombinant Noggin, and 50ng/ml hEGF). Subsequently, a 524 subclonal culture was derived according to protocol (Jager et al. 2018) . 525 526
Western blot 527
Protein samples from mouse organoid cultures were collected in Laemmli buffer and 528 measured using the Qubit extracted from every output file. Subsequently, genomic regions that were callable (1) in the 584 mouse organoid clone and the control (tail) sample, and (2) in the human organoid clone, 585 subclone, and control (blood) were intersected to define a genomic region that is surveyed in 586 all samples that were compared. Approximately 90 ± 1% of the autosomal genome was 587 surveyed in every mouse clone (Supplemental Table S2 ), and 73 -88% of the autosomal 588 genome was surveyed in each human subclone (Supplemental Table S5 ). Facility. Base substitutions were called as described in 'Base substitution and indel calling'. 647
Variants were considered true if they were called with a filter 'PASS' in 1 out of 12 samples. 648
The remaining 220 variants were checked manually in IGV and considered true if they were 649 found in 1 out of 12 samples at an allele frequency of > 10%. In total, 4,130/4,238 variants 650 (97.5%) were confirmed using this approach (Supplemental file S2). 651 652
Clonality of organoid cultures 653
We validated whether the organoid samples were clonal based on the VAF of somatic base 654 substitutions, before the final filter step (VAF < 0.3). Each cell acquires its own set of somatic 655 mutations and the reads supporting a mutation will be diluted in the WGS data of non-clonal 656 samples, resulting in a low VAF. After extensive filtering of somatic base substitutions, liver 657 organoid samples from WT1, WT2, and Ercc1 -/Δ 2 showed a shift in the VAF-peak away from 658 0.5 and therefore these samples were excluded from further analyses (Supplemental Fig.  659 S13 ). An additional liver organoid culture from these mice was sequenced and these 660 samples were confirmed to be clonal (Supplemental Fig. S13) . 1', 'mad-cutoff 9', 'min-flank 13', and 'geno-qual 5' (Rausch et al. 2012 ). We only considered 683
SVs of at least 100 bp on the autosomal chromosomes that were called with a filter 'PASS', 684
and a sample-specific genotype quality of at least 90 in the organoid culture and the control 685 sample. We subsequently excluded positions with any evidence in the control (tail) sample. 686
The filtered SVs were finally checked manually in IGV to reduce false-positives and we 687 excluded SVs present in the tail sample, with no visible change in the read-depth (for 688 duplications and deletions), and/or with many base substitutions in the region. 689 690 Genome-wide copy number profiles of Ercc1 -/Δ and WT mouse organoid cultures 691
To generate a virtual karyotype, genome-wide copy number states were determined using 692 FreeC v7.2 with settings 'ploidy 2', 'window 1000' and 'telocentromeric 50000' (Boeva et al. 693 2012) . Subsequently, the average copy number across bins of 500,000 bp was calculated 694 and plotted to assess genome stability. 695 696
Base substitution types 697
We retrieved the base substitution types from all the filtered VCF files, converted them to the 698 6 types of base substitutions that are distinguished by convention, and generated a mutation 699 spectrum (the C>T changes at NpCpG sites are considered separately from C>T changes at 700 other sites) for the four ASC groups (Ercc1 -/Δ liver, Ercc1 -/Δ small intestine, WT liver, and WT 701 small intestine), as well as XPC KO , XPC WT 1, XPC WT 2, and XPC WT 3 ASCs. X 2 -tests were 702 performed to determine whether the mutation spectra differ significantly between (1) mouse 703
WT and Ercc1
-/Δ liver ASCs, and (2) mouse WT and Ercc1 -/Δ small intestinal ASCs. P values 704 were corrected for multiple testing using Benjamini-Hochberg FDR correction, and 705 differences in mutation rates between Ercc1 -/Δ and WT mouse ASCs with q < 0.05 were 706 considered significant. Fig. S6B, Supplemental Fig. S10B ). We ranked the 734 COSMIC signatures based on the total contribution of these signatures to the centroids of 735 the mouse samples. Next, we iteratively reconstructed the centroids of the ASC groups, first 736 using the top 2 COSMIC signatures, and in each iteration the next COSMIC signature was 737 included until all 30 signatures were used. The cosine similarity was calculated between the 738 original and the reconstructed centroid for each mouse ASC group (Supplemental Fig. S6A) . 739
As expected, the addition of more signatures increases the similarity of the reconstructed 740 centroids with the original centroids, but after 10 COSMIC signatures the cosine similarities 741 plateau (Supplemental Fig. S6A ). Therefore, we used the signature contribution with this 742 subset of 10 COSMIC signatures to the centroids of the four ASC groups (Fig. 3B-C) . 743
Determination of the statistical significance of differences in signature contributions 745 A bootstrap resampling -similar to that performed in (Zou et al. 2018 ) -was applied to 746 generate 7,000 replicas of the 96-channel mutational profile of each WT liver ASC (n = 3), 747 which yielded 21,000 WT liver replicas in total. Subsequently, 3 replicas were randomly 748 selected and the relative contribution of 30 COSMIC signatures was determined for their 749 centroid. Euclidean distance dWT was calculated between the relative signature contributions 750 of the replicas centroid and that of the original centroid. This was repeated 10,000 times to 751 construct a distribution of dWT (Supplemental Figure 6C) . Next, the threshold distance with P 752 value = 0.05, dWT_0.05, was identified. The same approach was taken to generate 7,000 753 replicas of each Ercc1 -/Δ (MUT) liver ASC (n = 3) and construct a distribution of dMUT 754 (Supplemental Figure 6C To test whether the base substitutions appear more or less frequently than expected in 766 genes, promoters, promoter-flanking, and enhancer regions, we loaded the UCSC Known 767
Genes tables as TxDb objects for Mm10 (Team BC and Maintainer 2016) and Hg19 768 (Carlson and Maintainer 2015) , and the regulatory features for Mm10 and Hg19 from 769 Ensembl using biomaRt (Durinck et al. 2005 (Durinck et al. , 2009 Fig. S9A, Supplemental Fig. S10C ). Two-sided Poisson tests were performed 774 to test for significant differences in the ratio of base substitutions within a genomic region 775 divided by the total number of base substitutions between (1) mouse WT and Ercc1 -/Δ liver 776 ASCs and (2) mouse WT and Ercc1 -/Δ small intestinal ASCs (Supplemental Fig. S9A ). 777
Differences in mutation rates with q < 0.05 (Benjamini-Hochberg FDR multiple-testing 778 correction) were considered significant. 779
To test whether base substitutions occur more frequently in more highly expressed 780 genes in the NER-deficient mouse ASCs, we first selected base substitutions that occurred 781 within genes in the mouse ASCs. Per ASC group, we next determined the average Reads 782
Per Kilobase per Million mapped reads (RPKM) of these genes. Two-sided t-tests were 783 performed to test for significant difference in the average expression of genes that carry a 784 somatic mutation between (1) mouse WT and Ercc1 -/Δ liver ASCs, and (2) mouse WT and 785
Ercc1
-/Δ small intestinal ASCs (Supplemental Fig. S9B ). Differences in gene expression 786 distributions with q < 0.05 (Benjamini-Hochberg FDR multiple-testing correction) were 787 considered significant. 788
789
Transcriptional strand bias of base substitutions 790
For the base substitutions within genes we determined whether the mutations are located on 791 the transcribed or the non-transcribed strand. To this end, we determined whether the 792 mutated "C" or "T" base is on the same strand as the gene definition, which is untranscribed, 793 or the opposite strand, which is transcribed. We generated a 192-channel mutational profile 794 per ASC group with the relative contribution of each mutation type with separate bars for the 795 mutations on the transcribed and untranscribed strand, and calculated the significance of the 796 strand bias using a two-sided Poisson test with MutationalPatterns (Supplemental Fig. S9C , 797
Supplemental Fig. S10D ) (Blokzijl et al. 2018 ). Furthermore, we performed two-sided 798
Poisson tests to test whether there is a significant difference in strand bias per mutation type 799 between (1) mouse WT and Ercc1 -/Δ liver ASCs and (2) mouse WT and Ercc1 -/Δ small 800 intestinal ASCs (Supplemental Fig. S9C ). Differences in strand bias with an adjusted P-value 801 q < 0.05 (Benjamini-Hochberg FDR multiple-testing correction) were considered significant. 802
803
Calculation and comparison of mutation rates 804
To calculate the mutation rates per genome per week, we quantified the number of somatic 805 base substitutions, double nucleotide mutations, indels, and SVs for each mouse ASC. 806
Moreover, we quantified the number of base substitutions, double base substitutions and 807
Signature 8 mutations for the human ASCs. All event counts were extrapolated to the entire 808 autosomal genome using the callable genome length (see" Callable genome") for both 809 mouse and human ASCs to correct for differences in the surveyed genome. Subsequently, 810 the mutation rates were calculated by dividing the extrapolated number of mutations by the 811 number of weeks in which the mutations were accumulated (WT and Ercc1 The number of base substitutions was extracted from each VCF file and a Wilcoxon 836 rank-sum test was performed to determine whether the number of base substitutions is 837 different between NER-proficient and NER-deficient samples. The 96-channel mutational 838 profile of each sample was generated as described in the section "Base substitution types". 839
Subsequently, the 96-channel mutational profile of each sample was reconstructed using the 840 30 mutational signatures from COSMIC, as described in the section "Quantification of the 841 contribution of COSMIC mutational signatures to the 96-channel mutational profiles". 842
Signatures with a contribution of < 10% in all 344 samples were excluded (signatures 4, 7, 843 10, 11, 14, 15, 22-25, 27, 28), and the 96-channel mutational profiles were finally 844 reconstructed using the remaining 18 signatures. The cosine similarity between the 845 observed 96-channel mutational profile and the reconstructed profile was above 0.95 for all 846 samples, which indicates a very good fit of the signatures. 847
Based on this, the number of mutations per signature was estimated for each 848 sample. Then, for each signature, the number of mutations was compared between the 849 NER-deficient and NER-proficient samples using the median difference (the median of all 850 pairwise differences between NER-deficient and NER-proficient samples). A Wilcoxon rank- 
